--- title: "Hormone Support Peptides | PepTracker Pro" url: https://peptrackerpro.com/benefits/hormone-support description: "Peptides studied for supporting hormonal balance and endocrine function." lang: en --- Skip to main content **Educational information only.** This site does not provide medical advice. Read full disclaimer (https://peptrackerpro.com/disclaimer) # Hormone Support Peptides Peptides studied for supporting hormonal balance and endocrine function. ### Abaloparatide High Evidence Abaloparatide (Tymlos) is a synthetic 34-amino-acid analog of parathyroid hormone-related protein, PTHrP(1-34), engineered to bind the PTH1 receptor with a strong preference for its transient RG conformation rather than the long-lived R0 conformation favored by teriparatide. That receptor bias produces a shorter burst of signaling per injection - enough to drive osteoblast activity, but short enough to limit the bone resorption and calcium mobilization that follow a prolonged signal. In the 18-month Phase 3 ACTIVE trial in 2,463 postmenopausal women, abaloparatide 80 mcg daily reduced new morphometric vertebral fractures by 86% versus placebo, alongside significant reductions in nonvertebral, major osteoporotic and clinical fractures. The FDA approved Tymlos in April 2017; in December 2021 the osteosarcoma boxed warning and the two-year cumulative lifetime limit were both removed from the label. Bone Growth (https://peptrackerpro.com/benefits/bone-growth)Rare Disease Treatment (https://peptrackerpro.com/benefits/rare-disease-treatment)Hormone Support (https://peptrackerpro.com/benefits/hormone-support)Disease Modification (https://peptrackerpro.com/benefits/disease-modification)+1 more View Details: https://peptrackerpro.com/peptides/abaloparatide \+ Compare: https://peptrackerpro.com/compare?select=abaloparatide Track in App: https://app.peptrackerpro.com/?add=abaloparatide ### GHRP-2 Medium Evidence A synthetic hexapeptide growth hormone secretagogue studied for its potent stimulation of growth hormone release via the ghrelin receptor. Hormone Support (https://peptrackerpro.com/benefits/hormone-support)Recovery (https://peptrackerpro.com/benefits/recovery)Muscle Growth (https://peptrackerpro.com/benefits/muscle-growth)Sleep (https://peptrackerpro.com/benefits/sleep)+1 more View Details: https://peptrackerpro.com/peptides/ghrp-2 \+ Compare: https://peptrackerpro.com/compare?select=ghrp-2 Track in App: https://app.peptrackerpro.com/?add=ghrp-2 ### HCG High Evidence A hormone used clinically for fertility treatment and testosterone support during hormone replacement therapy. Hormone Support: https://peptrackerpro.com/benefits/hormone-support Fertility: https://peptrackerpro.com/benefits/fertility Sexual Health: https://peptrackerpro.com/benefits/sexual-health View Details: https://peptrackerpro.com/peptides/hcg \+ Compare: https://peptrackerpro.com/compare?select=hcg Track in App: https://app.peptrackerpro.com/?add=hcg ### HMG High Evidence A gonadotropin preparation containing FSH and LH, used in fertility protocols for both men and women. Fertility: https://peptrackerpro.com/benefits/fertility Hormone Support: https://peptrackerpro.com/benefits/hormone-support View Details: https://peptrackerpro.com/peptides/hmg \+ Compare: https://peptrackerpro.com/compare?select=hmg Track in App: https://app.peptrackerpro.com/?add=hmg ### Insulin Efsitora Alfa High Evidence A once-weekly basal insulin engineered as a single-chain insulin analog fused to an antibody (IgG2) Fc fragment, giving it a roughly 17-day half-life so a single subcutaneous injection covers a full week. Developed by Eli Lilly (code LY3209590, also called basal insulin Fc or BIF), efsitora is designed to replace daily long-acting insulin with a flat, ultra-stable weekly profile. In the large Phase 3 QWINT program it matched daily insulins glargine and degludec on A1C in type 2 diabetes, and in insulin-naive patients its simplified fixed-dose titration cut the number of dose adjustments dramatically while keeping hypoglycemia low. In type 1 diabetes (QWINT-5) it was non-inferior on A1C but showed a higher rate of severe hypoglycemia, a key safety caveat. As of mid-2026 efsitora is under FDA review for type 2 diabetes (a decision expected in the third quarter of 2026) and would compete directly with Novo Nordisk's once-weekly insulin icodec (Awiqli). Glycemic Control: https://peptrackerpro.com/benefits/glycemic-control Hormone Support: https://peptrackerpro.com/benefits/hormone-support View Details: https://peptrackerpro.com/peptides/insulin-efsitora-alfa \+ Compare: https://peptrackerpro.com/compare?select=insulin-efsitora-alfa Track in App: https://app.peptrackerpro.com/?add=insulin-efsitora-alfa ### Kisspeptin-10 Medium Evidence A neuropeptide that stimulates GnRH release, studied for fertility and reproductive hormone regulation. Fertility: https://peptrackerpro.com/benefits/fertility Hormone Support: https://peptrackerpro.com/benefits/hormone-support Sexual Health: https://peptrackerpro.com/benefits/sexual-health View Details: https://peptrackerpro.com/peptides/kisspeptin-10 \+ Compare: https://peptrackerpro.com/compare?select=kisspeptin-10 Track in App: https://app.peptrackerpro.com/?add=kisspeptin-10 ### Navepegritide High Evidence A C-type natriuretic peptide (CNP) analog FDA-approved in February 2026 for increasing linear growth in children with achondroplasia — the first once-weekly CNP therapy. Joint Health: https://peptrackerpro.com/benefits/joint-health Hormone Support: https://peptrackerpro.com/benefits/hormone-support View Details: https://peptrackerpro.com/peptides/navepegritide \+ Compare: https://peptrackerpro.com/compare?select=navepegritide Track in App: https://app.peptrackerpro.com/?add=navepegritide ### Oxytocin High Evidence A neuropeptide involved in social bonding, mood regulation, and reproductive functions. Mood: https://peptrackerpro.com/benefits/mood Anxiety Relief: https://peptrackerpro.com/benefits/anxiety-relief Hormone Support: https://peptrackerpro.com/benefits/hormone-support View Details: https://peptrackerpro.com/peptides/oxytocin \+ Compare: https://peptrackerpro.com/compare?select=oxytocin Track in App: https://app.peptrackerpro.com/?add=oxytocin ### Palopegteriparatide High Evidence Palopegteriparatide (Yorvipath, developed as TransCon PTH) is Ascendis Pharma's once-daily prodrug of parathyroid hormone (1-34). An inert methoxy-PEG carrier is attached to PTH(1-34) through a TransCon linker that auto-cleaves at physiologic pH and temperature, releasing unmodified native-sequence PTH slowly enough to hold hormone levels inside the physiologic range for a full 24 hours. It is the first therapy approved as a true hormone replacement for chronic hypoparathyroidism rather than as an add-on to calcium and active vitamin D: in the Phase 3 PaTHway trial 78.7% of treated adults met a composite endpoint of normal serum calcium plus independence from conventional therapy at week 26, versus 4.8% on placebo. The FDA approved Yorvipath on August 9, 2024. Rare Disease Treatment (https://peptrackerpro.com/benefits/rare-disease-treatment)Hormone Support (https://peptrackerpro.com/benefits/hormone-support)Bone Growth (https://peptrackerpro.com/benefits/bone-growth)Disease Modification (https://peptrackerpro.com/benefits/disease-modification)+1 more View Details: https://peptrackerpro.com/peptides/palopegteriparatide \+ Compare: https://peptrackerpro.com/compare?select=palopegteriparatide Track in App: https://app.peptrackerpro.com/?add=palopegteriparatide Track Your Research with PepTracker Pro Try the Free App → (https://app.peptrackerpro.com/)